The role of lymph node assessment along with sublobar resection is now evident, but what about the role of sublobar resection in small non-small cell lung cancer?

Yendamuri et al. published an important work in the Journal of Thoracic and Cardiovascular Surgery in July 2018 on the effects of the number of resected lymph nodes (LNs) on the survival of patients with small-sized (≤2 cm) non-small cell lung cancer (NSCLC) who underwent sublobar resection (1). This retrospective analysis was based on the Surveillance, Epidemiology, and End Results (SEER) database in the United States with more than 3,900 cases (study period: 2004–2013).